Alaunos Therapeutics, Inc. (TCRT): Free Cash Flow
-$2.97M
Year ended 2025-12-31
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$2.97M | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$4.97M | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$30.34M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$29.45M | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$64.79M | n/m | 2023-03-07, From 2021-01-01 |
| 2020-12-31 | -$66.79M | n/m | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | -$41.14M | n/m | 2021-03-01, From 2019-01-01 |
| 2018-12-31 | -$49.92M | n/m | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | -$55.41M | n/m | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | -$58.88M | n/m | 2019-03-05, From 2016-01-01 |
| 2015-12-31 | -$422.0K | n/m | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | -$36.84M | n/m | 2017-02-16, From 2014-01-01 |
| 2013-12-31 | -$59.64M | n/m | 2016-02-24, From 2013-01-01 |
| 2012-12-31 | -$80.39M | n/m | 2015-02-26, From 2012-01-01 |
| 2011-12-31 | -$39.99M | n/m | 2014-03-03, From 2011-01-01 |
| 2010-12-31 | -$19.88M | n/m | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | -$12.30M | n/a | 2012-02-29, From 2009-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | -$2.97M | n/m |
| Aditxt, Inc. (ADTX) | 2025-12-31 | -$25.70M | n/a |
| Genelux Corp (GNLX) | 2025-12-31 | -$26.37M | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | -$3.96M | n/m |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | -$534.0K | n/m |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | -$42.5K | n/m |
| Talphera, Inc. (TLPH) | 2024-12-31 | -$12.68M | n/m |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | -$150.80M | n/m |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$20.86M | n/a |
Compare TCRT, ADTX, GNLX, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗